Volumina Medical

Volumina Medical is a Swiss Medtech start-up founded in 2018 and is a spin-off from the Swiss Federal Institute of Technology in Lausanne (EPFL). The company focuses on developing innovative biomaterials for regenerative medicine, particularly in reconstructive surgery and soft tissue engineering. Their main product, AdiPearl™, is an injectable biomaterial designed to reconstruct soft tissues such as fat, muscles, and connective tissues lost due to various conditions. AdiPearl™ is minimally invasive, allowing for injections through thin cannulas, which reduces recovery times. It mimics the softness and structure of natural tissues, providing a natural feel and appearance. Volumina Medical aims to make reconstructive surgery more accessible, particularly for breast cancer patients, by offering a single, efficient procedure that minimizes risks and costs. The company is supported by innovation accelerators and has successfully completed Series pre-A funding rounds to advance the development of AdiPearl™. Volumina Medical is dedicated to addressing unmet medical needs in plastic and reconstructive surgery, providing safe and effective solutions for patients.

• Employees 10
• Founded 2018
• Total Funding $21566044